處於科技快速變遷的世代中，研發不再是維持持久性競爭優勢的唯一方式，而尋找與發展公司內部性與外部性的競爭優勢的來源，是當今最大的挑戰與難題。本次研究的主題是探討醫藥生物科技的業務人員的業績績效與授權之間的關聯性。我們針對業務人員的五項任務﹕市場及客戶資訊收集及分析、銷售策略制定、現場銷售、客戶溝通、客戶服務等等，分析其授權相對應的成本與效益項目，以了解不同的授權程度如何影響業務團隊的績效﹔並探討不同業務地區、職位與年資如何影響授權的成本與效益項目。我們藉由問卷得到了下列幾項初步的結論﹕
1.業務人員之授權程度高者對銷售績效表現較佳
2.授權程度應以地區不同而異
3.不同年資之業務人員因經驗知識之累積不同對授權看法不同
4.職等不同對授權的看法不同成立
此研究之初步結果提供給有意願要研究授權機制的研究人員一個思考的方向與參考。

Rapid changes in technology generation are to accelerate the competition of bio-pharmaceutical industry. Today’s greatest challenges and problems in such a fast change, R & D is no longer a sustainable competitive advantage to maintain the only way to find and develop the internal resistance and external sources of competitive advantage. The main theme of this study was to explore the correlation between the team sales per-formance of medical sales representative in biopharmaceutical and the cost or benefit of delegation.
This study tried to find the implementation from the 5 major tasks; market and customer information collection and analysis, sales strategy development, field sales, customer communication, customer service. Analysis the delegation rela-tive costs and benefits should be to understand the effect of delegation on performance of the sales team. To explore different areas, positions and working experience which affect the costs and benefits of delegation. Through survey we got the preliminary con-clusions are in below:
1.The high effect of delegation induced the high sales performance.
2.Different Area will impact the effect of delegation.
3.The sales representatives will have different opinion of delegation due to the experience of assemble knowledge.
4.The position will reflect the different opinion of delegation.
The preliminary results of this study will provide a mechanism to empower re-searchers to reflect on the direction and reference.

1.Bengt Holmstrom & Paul Milgrom, (1994), “HOLMSTROM AND MILGROM: The Firm as an Incentive System”, The American Eco-nomic Review September, Vol. 84, No. 4.
2.Besanko, D., Dranove, D., Shanley, M. & Schaefer, S. (2007), “Eco-nomics of Strategy”, 4rd Edition.
3.Brickley, Smith, Zimmerman, “Managerial Economic & Orfaniza-tional Architecture” Fourth Edition
4.David J. Teece, Gary Pisano & Amy Shen, (1997), “Dynamic Capa-bility and Strategic Management”, Strategic Management Journal, Vol. 18, No. 7, 508-533.
5.Frank Moers, (2006), “Performance Measure Properties and Delega-tion”, The Account Review Vol. 81, No. 4.
6.George Baker, (2000), “The Use of Performance in Incentive Con-tracting”, The American Economic Review, Vol. 90, No. 2.
7.Margaret A. Abernethy, (2004), “Determinants of Control System Design in Divisionalized Firms, The Accounting Review, Vol. 79, No. 3.
8.Neil A. Morgan, Douglas W. Vorhies, & Charlotte H. Mason, (2009), “Research Notes and Commentaries”, Strat. Mgmt. J., Vol. 30, 909-920.
9.Nelson & Winter (2001), “The Nature and Dynamics of Organiza-tional Capabilities”.
10.Rebecca Henderson & Iain Cockburn, (2001), “Measuring Compe-tence? Exploring Firm Effects in Drug Discovery”, the Nature Dy-namic of Organization Capability, 155-182.
11.Robert M. Grant, (1996), “Prospering in Dynamically-Competitive Environments: Organizational Capability as Knowledge Integration” Organization Science, Vol. 7, No. 4, 375-387.
12.Rodolphe Durand, (2003), “Predicting A Firm’s Forecasting Ability: The Roles Of Organizational Illusion Of Control And Organizational Attention”, Strat. Mgmt. J., Vol. 24: 821-838.
13.Sendil K. Ethiraj, Prashant Kale, M. S. Krishnan & Jitendra V. Singh, (2005), “Where Do Capability Come From And How Do They Mat-ter? A Study In The Software Service Industry”, Strat. Mgmt. J., Vol. 26, 25-45.
14.Shantanu Dutta, Mark J. Zbaracki & Mark Bergen, (2003), “Pricing Process As A Capability: A Resource-Based Perspective”, Strategic Management Journal, Vol. 24, 615-630.
15.Sijun Wang & Yuanjie He, (2008), “Compensating Nondedi-cated Cross-Functional Teams”, Organization Science Vol. 19, No. 5, 753-765.
16.經濟部工業局(2009)，生技產業白皮書。